Trigeminal autonomic cephalalgias: Diagnosis and treatment

Current Neurology and Neuroscience Reports

Volumn 7, Issue 2, 2007, Pages 117-125

  Goadsby, Peter J ^a   Cohen, Anna S ^b   Matharu, Manjit S ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; ERGOTAMINE; FLUNARIZINE; GABAPENTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; LAMOTRIGINE; LIDOCAINE; LITHIUM; LOCAL ANESTHETIC AGENT; METHYSERGIDE; OCTREOTIDE; OXYGEN; PIZOTIFEN; PLACEBO; PREDNISOLONE; PROTON PUMP INHIBITOR; ROFECOXIB; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID; VERAPAMIL; ZOLMITRIPTAN;

ADJUVANT THERAPY; BRAIN DEPTH STIMULATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; CLUSTER HEADACHE; DECOMPRESSION SURGERY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HEART BLOCK; HEART INFARCTION; HEART MUSCLE FIBROSIS; HUMAN; LUNG FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PAROXYSMAL HEMICRANIA; PATHOPHYSIOLOGY; PATIENT EDUCATION; PEPTIC ULCER; PERIODICITY; PHYSICAL DISABILITY; PLEURAL FIBROSIS; PRIMARY HEADACHE; RETROPERITONEAL FIBROSIS; REVIEW; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SUNCT SYNDROME; SURGICAL TECHNIQUE; TRIGEMINAL AUTONOMIC CEPHALALGIA; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; HUMANS; TRIGEMINAL AUTONOMIC CEPHALALGIAS; TRYPTAMINES;

EID: 33947288621     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-007-0006-6     Document Type: Review

References (78)

1. Goadsby PJ, Lipton RB: A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 1997, 120:193-209.
2. Goadsby PJ: Trigeminal autonomic cephalalgias. Pathophysiology and classification. Rev Neurol (Paris) 2005, 161:692-695.
3. Headache Classification Committee of The International Headache Society: The International Classification of Headache Disorders (second edition). Cephalalgia 2004, 24(Suppl 1):1-160.
4. Bahra A, May A, Goadsby PJ: Cluster headache: a prospective clinical study in 230 patients with diagnostic implications. Neurology 2002, 58:354-361.
5. Silberstein SD, Niknam R, Rozen TD, Young WB: Cluster headache with aura. Neurology 2000, 54:219-221.
6. Levy M, Matharu MS, Meeran K, et al.: The clinical characteristics of headache in patients with pituitary tumours. Brain 2005, 128:1921-1930.
7. Goadsby PJ: Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol 2002, 1:37-43.
8. May A, Bahra A, Buchel C, et al.: Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275-278.
9. May A, Ashburner J, Buchel C, et al.: Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999, 5:836-838.
10. Ekbom K; The Sumatriptan Cluster Headache Study Group: Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991, 325:322-326.
11. Ekbom K, Waldenlind E, Cole JA, et al.: Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia 1992, 12:254-256.
12. van Vliet JA, Bahra A, Martin V, et al.: Intranasal sumatriptan in cluster headache - randomized placebo-controlled double-blind study. Neurology 2003, 60:630-633.
13. Cittadini E, May A, Straube A, et al.: Effectiveness of intranasal zolmitriptan in acute cluster headache. A randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006, In press.
14. Monstad I, Krabbe A, Micieli G, et al.: Preemptive oral treatment with sumatriptan during a cluster period. Headache 1995, 35:607-613.
15. Paemeleire K, Bahra A, Evers S, et al.: Medication-overuse headache in cluster headache patients. Neurology 2006, 67:109-113.
16. Fogan L: Treatment of cluster headache: a double blind comparison of oxygen vs air inhalation. Arch Neurol 1985, 42:362-363.
17. Matharu MS, Levy MJ, Meeran K, Goadsby PJ: Subcutaneous octreotide in cluster headache - randomized placebo-controlled double-blind cross-over study. Ann Neurol 2004, 56:488-494.
18. Robbins L: Intranasal lidocaine for cluster headache. Headache 1995, 35:83-84.
19. Couch JR, Ziegler DK: Prednisone therapy for cluster headache. Headache 1978, 18:219-221.
20. Curran DA, Hinterberger H, Lance JW: Methysergide. Res Clin Studies Headache 1967, 1:74-122.
21. Ambrosini A, Vandenheede M, Rossi P, et al.: Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain 2005, 118:92-96.
22. Anthony M: Arrest of attacks of cluster headache by local steroid injection of the occipital nerve. In Migraine: Clinical and Research Advances. Edited by Rose FC. London: Karger; 1985:169-173.
23. Afridi SK, Shields KG, Bhola R, Goadsby PJ: Greater occipital nerve injection in primary headache syndromes - prolonged effects from a single injection. Pain 2006, 122:126-129.
24. Shields KG, Levy MJ, Goadsby PJ: Alopecia and cutaneous atrophy following greater occipital nerve infiltration. Neurology 2004, 63:2193-2194.
25. Gabai IJ, Spierings EL: Prophylactic treatment of cluster headache with verapamil. Headache 1989, 29:167-168.
26. Bussone G, Leone M, Peccarisi C, et al.: Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990, 30:411-417.
27. Leone M, D'Amico D, Frediani F, et al.: Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology 2000, 54:1382-1385.
28. Cohen AS, Matharu MS, Goadsby PJ: ECG abnormalities on verapamil in cluster headache. Cephalalgia 2005, 25:1200.
29. Ekbom K: Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 1981, 21:132-139.
30. Goadsby PJ, Schoenen J, Ferrari MD, et al.: Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia 2006, 26:1168-1170.
31. Leone M, Franzini A, Broggi G, Bussone G: Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology 2006, 67:150-152.
32. Dodick DW, Trentman T, Zimmerman R, Eross EJ: Occipital nerve stimulation for intractable chronic primary headache disorders. Cephalalgia 2003, 23:701.
33. Antonaci F, Costa A, Ghirmai S, et al.: Parenteral indomethacin (the INDOTEST) in cluster headache. Cephalalgia 2003, 23:193-196.
34. Matharu MS, Goadsby PJ: Functional brain imaging in hemicrania continua: implications for nosology and pathophysiology. Curr Pain Headache Rep 2005, 9:281-288.
35. Cohen AS, Goadsby PJ: Short-lasting Unilateral Neuralgiform Headache Attacks with Conjunctival injection and Tearing (SUNCT) or Cranial Autonomic Features (SUNA). A prospective clinical study of SUNCT and SUNA. Brain 2006, 129:2746-2760.
36. Antnaci F, Slaastad O: Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989, 29:648-656.
37. Cittadini E, Goadsby PJ: Revisiting the International Headache Society criteria for paroxysmal hemicrania: a case series of 21 patients. Cephalalgia 2006, 26:1401-1402.
38. Russell D: Paroxysmal hemicrania. In Cluster Headache & Related Conditions. Edited by Olesen J, Goadsby PJ. Oxford: Oxford University Press; 1999:27-36.
39. Boes CJ, Swanson JW, Dodick DW: Chronic paroxysmal hemicrania presenting as otalgia with a sensation of external acoustic meatus obstruction: two cases and a pathophysiologic hypothesis. Headache 1998, 38:787-791.
40. Irimia P, Cittadini E, Paemeleire K, Cohen A, et al.: Unilateral phonophobia and photophobia: a helpful symptom for the diagnosis of trigeminal autonomic cephalalgias (TACs) and hemicrania continua (HC). Cephalalgia 2005, 25:856.
41. Boes CJ, Dodick DW: Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache 2002, 42:699-708.
42. Goadsby PJ, Edvinsson L: Neuropeptide changes in a case of chronic paroxysmal hemicrania - evidence for trigeminoparasympathetic activation. Cephalalgia 1996, 16:448-450.
43. Goadsby PJ, Edvinsson L: Human in vivo evidence for trigeminovascular activation in cluster headache. Brain 1994, 117:427-434.
44. May A, Goadsby PJ: The trigeminovascular system in humans: pathophysiological implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999, 19:115-127.
45. Antonaci F, Sandrini G, Danilov A, Sand T: Neurophysiological studies in chronic paroxysmal hemicrania and hemicrania continua. Headache 1994, 34:479-483.
46. Micieli G, Cavallini A, Facchinetti F, et al.: Chronic paroxysmal hemicrania: a chronobiological study (case report). Cephalalgia 1989, 9:281-286.
47. Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ: Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol 2006, 59:535-545.
48. Cohen AS, Goadsby PJ: Functional neuroimaging of primary headache disorders. Exp Rev Neurotherapeut 2006, 6:1159-1172.
49. Sjaastad O: Chronic paroxysmal hemicrania. In Handbook of Clinical Neurology. Edited by Vinken PJ, Bruyn GW, Klawans HL, Rose FC. Amsterdam: Elsevier Science; 1986:257-266.
50. Sjaastad O, Apfelbaum R, Caskey W, et al.: Chronic paroxysmal hemicrania (CPH). The clinical manifestations. A review. Uppsala J Med Sci 1980, 31(Suppl):27-33.
51. Lisotto C, Maggioni F, Mainardi F, Zanchin G: Rofecoxib for the treatment of chronic paroxysmal hemicrania. Cephalalgia 2003, 23:318-320.
52. Chakravarty A, Mukherjee A, Roy D: Trigeminal autonomic cephalgias and variants: clinical profile in Indian patients. Cephalalgia 2004, 24:859-866.
53. Siow HC: Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors. Cephalalgia 2004, 24:414-415.
54. Mathew NT, Kailasam J, Fischer A: Responsiveness to celecoxib in chronic paroxysmal hemicrania. Neurology 2000, 55:316.
55. Lenzer J: FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke. BMJ 2005, 330:440.
56. Evers S, Husstedt IW: Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache 1996, 36:429-432.
57. Coria F, Claveria LE, Jimenez-Jimenez FJ, Seijas EV: Episodic paroxysmal hemicrania responsive to calcium channel blockers. J Neurol Neurosurg Psychiatry 1992, 55:166.
58. Cohen AS, Goadsby PJ: Paroxysmal hemicrania responding to topiramate. J Neurol Neurosurg Psychiatry 2007, 78:96-97.
59. Antonaci F, Pareja JA, Caminero AB, Sjaastad O: Chronic paroxysmal hemicrania and hemicrania continua: anaesthetic blockades of pericranial nerves. Funct Neurol 1997, 12:11-15.
60. Matharu MS, Cohen AS, Boes CJ, Goadsby PJ: SUNCT syndrome: a review. Curr Pain Headache Rep 2003, 7:308-318.
61. Cohen AS, Matharu MS, Goadsby PJ: Suggested guidelines for treating SUNCT and SUNA. Cephalalgia 2005, 25:1200.
62. May A, Bahra A, Buchel C, et al.: Functional MRI in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 1999, 46:791-793.
63. Cohen AS, Matharu MS, Kalisch R, et al.: Functional MRI in SUNCT (Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing) and SUNA (Short-lasting Unilateral Neuralgiform headache attacks with cranial Autonomic symptoms) shows differential hypothalamic activation with increasing pain. Cephalalgia 2006, 26:1402-1403.
64. Matharu MS, Cohen AS, Goadsby PJ: SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia 2004, 24:985-992.
65. Matharu MS, Boes CJ, Goadsby PJ: Management of trigeminal autonomic cephalalgias and hemicrania continua. Drugs 2003, 63:1637-1677.
66. Black DF, Dodick DW: Two cases of medically and surgically intractable SUNCT: a reason for caution and an argument for a central mechanism. Cephalalgia 2002, 22:201-204.
67. Sprenger T, Valet M, Platzer S, et al.: SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain 2005, 113:422-426.
68. Rossi P, Cesarino F, Faroni J, et al.: SUNCT syndrome successfully treated with topiramate: case reports. Cephalalgia 2003, 23:998-1000.
69. Matharu MS, Boes CJ, Goadsby PJ: SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology 2002, 58:1307.
70. Koseoglu E, Karaman Y, Kucuk S, Arman F: SUNCT syndrome associated with compression of trigeminal nerve. Cephalalgia 2005, 25:473-475.
71. Volcy M, Tepper S, Rapoport A, et al.: Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) - a case report. Cephalalgia 2005, 25:470-472.
72. Cohen AS: Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia 2006, In press.
73. Lenaerts M, Diederich N, Phuoe D: A patient with SUNCT cured by the Jannetta procedure. Cephalalgia 1997, 17:460.
74. Gardella L, Viruega A, Rojas H, Nagel J: A case of a patient with SUNCT syndrome treated with Jannetta procedure. Cephalalgia 2001, 21:996-999.
75. Pareja JA, Kruszewski P, Sjaastad O: SUNCT syndrome: trials of drugs and anesthetic blockades. Headache 1995, 35:138-142.
76. Peres MF, Stiles MA, Siow HC, et al.: Greater occipital nerve blockade for cluster headache. Cephalalgia 2002, 22:520-522.
77. Cohen AS, Matharu MS, Kalisch R, et al.: Functional MRI in SUNCT shows differential hypothalamic activation with increasing pain. Cephalalgia 2004, 24:1098-1099.
78. Leone M, Franzini A, D'Andrea G, et al.: Deep brain stimulation to relieve drug-resistant SUNCT. Ann Neurol 2005, 57:924-927.